TheraRadar
← All Biomarkers

TNF-alpha

20 drugs

Tumor Necrosis Factor Alpha

Predictive biomarker for patient selection in 23 indications

Understanding TNF-alpha

What it means: TNF-alpha is a key inflammatory cytokine produced by macrophages. Drives inflammation in rheumatoid arthritis, IBD, and psoriasis.
Why it matters: Anti-TNF biologics (Humira, Remicade, Enbrel) are among the most successful drugs ever, controlling autoimmune inflammation.
Testing: Not routinely tested. Anti-TNF drugs selected based on diagnosis. TB screening required before starting treatment.
20
Approved Drugs
23
Indications
15
Companies
Search TNF-alpha Clinical Trials

Search recruiting trials on ClinicalTrials.gov

Drugs Targeting TNF-alpha

Drug Company Therapeutic Area
ABRILADA Pfizer Immunology
AMJEVITA Amgen Immunology
AVSOLA Amgen Immunology
CIMZIA UCB INC Immunology
CYLTEZO Boehringer Ingelheim Immunology
ENBREL IMMUNEX Immunology
HADLIMA SAMSUNG BIOEPIS CO LTD Immunology
HULIO Viatris Immunology
HUMIRA AbbVie Immunology
HYRIMOZ Novartis Immunology
IDACIO Fresenius Kabi Immunology
INFLECTRA CELLTRION INC Immunology
REMICADE Johnson & Johnson Immunology
RENFLEXIS SAMSUNG BIOEPIS CO LTD Immunology
SIMLANDI ALVOTECH USA INC Immunology
SIMPONI Johnson & Johnson Immunology
SIMPONI ARIA Johnson & Johnson Immunology
YUFLYMA CELLTRION Immunology
YUSIMRY COHERUS BIOSCIENCES INC Immunology
ZYMFENTRA CELLTRION Immunology